Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
66,729,680
-
Total 13F shares
-
4,044,287
-
Share change
-
+3,736,670
-
Total reported value
-
$56,123,192
-
Put/Call ratio
-
106%
-
Price per share
-
$13.88
-
Number of holders
-
83
-
Value change
-
+$53,680,856
-
Number of buys
-
77
-
Number of sells
-
7
Institutional Holders of INOVIO PHARMACEUTICALS, INC. - Common Stock (INO) as of Q1 2024
As of 31 Mar 2024,
INOVIO PHARMACEUTICALS, INC. - Common Stock (INO) was held by
83 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,044,287 shares.
The largest 10 holders included
VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC, STATE STREET CORP, GSA CAPITAL PARTNERS LLP, Qube Research & Technologies Ltd, and HRT FINANCIAL LP.
This page lists
83
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.